Drug Topics

OCTOBER 11, 2023

The National Community Pharmacists Association (NCPA) is leading the way on PBM reform. Ginny Langbehn, vice president of marketing and communications at American Associated Pharmacies (AAP) sat down with B. Douglas Hoey, RPh, MBA, CEO of the National Community Pharmacists Association (NCPA) and Anne Cassity, JD, NCPA’s senior vice president of government affairs, to discuss challenges in the PBM model, recent state- and federal-level legislative activity to reign in PBM practices, and much more

Independent Pharmacies 199

Independent Pharmacies Communication 199

STAT

OCTOBER 11, 2023

BRISTOL, Va. — Stephanie Rosenwinge was excited to work for the queen of abortion. She’d grown up in rural Virginia with an abusive, alcoholic father. Her mother had had an abortion in 1973, and it may have saved her life: As Rosenwinge put it, “My dad was determined to beat the baby out of her.” Rosenwinge herself had been sexually assaulted while serving in the Gulf War, and she was glad she would’ve had a constitutional right to terminate had the attack resu

145

145

Drug Topics

OCTOBER 11, 2023

Nonpharmaceutical interventions used during the COVID-19 pandemic may have affected the current epidemiology of respiratory infections in pediatric patients.

163

163

STAT

OCTOBER 11, 2023

Scientists at a Massachusetts-based biotechnology company and their academic research partners reported Wednesday that an engineered breed of miniature pig containing up to 69 genetic changes produced kidneys that functioned well in monkeys for an average of 176 days and in one animal for more than two years. The results, published in Nature , are an encouraging sign that the long-struggling science of xenotransplantation might one day become a medical reality.

Hospitals 144

Hospitals 144

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

Drug Topics

OCTOBER 11, 2023

Hybrid closed-loop insulin therapy adjusts insulin doses every 10 to 12 minutes by using a smartphone algorithm to communicate with continuous glucose monitoring devices and insulin pump systems.

Communication 94

Communication 94

STAT

OCTOBER 11, 2023

LAS VEGAS – Nick Jonas is a global superstar behind electrifying earworms like “Jealous,” “Chains,” and “Sucker,” one-third of the illustrious band The Jonas Brothers — and also a person who lives with type 1 diabetes. He took time out of his world tour to sit down with STAT’s Nicholas St.

141

141

STAT

OCTOBER 11, 2023

It’s no secret that biotech industry funding has fallen from its Covid highs. But with just a few months left in the year, it’s on track to hit lows that predate the pandemic. New data from Pitchbook and the National Venture Capital Association show that both the number of deals and the amount of money that’s being invested in life science companies are down significantly.

136

136

Pharmacy Times

OCTOBER 11, 2023

The study authors note that it is important for expectant mothers to use antibiotics appropriately and when necessary, as well as monitor their child after birth.

101

101

STAT

OCTOBER 11, 2023

AI has the ability to revolutionize human health. It is  used to detect  potentially cancerous lesions in medical images, to screen for eye disease, and to predict whether a patient in the intensive care unit could have a brain-damaging seizure. Even your smartwatch has AI built into it; it can estimate your heart rate and detect whether you have atrial fibrillation.

Hospitals 134

Hospitals 134

Pharmacy Times

OCTOBER 11, 2023

Aducanumab, lecanemab, and donanemab are novel monoclonal antibodies designed to slow disease progression and hopefully have a positive impact in the field of Alzheimer disease management.

123

123

Speaker: Dr. Ben Locwin - Biopharmaceutical Executive & Healthcare Futurist

What will the future hold for clinical research? A recent draft from the FDA provides valuable insight. In "Optimizing the Dosage of Human Prescription Drugs and Biological Products for the Treatment of Oncologic Diseases," the FDA notes that "targeted therapies demonstrate different dose-response relationships compared to cytotoxic chemotherapy, such that doses below the Maximum Tolerated Dose (MTD) may have similar efficacy to the MTD but with fewer toxicities.

FDA

Fierce Pharma

OCTOBER 11, 2023

For a study weighing the injectable semaglutide in chronic kidney disease, an early end appears to give Novo Nordisk cause to celebrate. | For a study weighing the injectable semaglutide in chronic kidney disease, an early end appears to give Novo Nordisk cause to celebrate.

129

129

Pharmacy Times

OCTOBER 11, 2023

Pharmacy Times will be providing exclusive session coverage and interviews with presenters for the Academy of Managed Care Pharmacy Nexus 2023 conference.

132

132

Fierce Healthcare

OCTOBER 11, 2023

LAS VEGAS—A new analysis finds that mor | LAS VEGAS—A new analysis finds that more pharmacists are electronically prescribing medications as they assist in managing chronic disease, which offers a peek at the next evolution in primary care.

128

128

STAT

OCTOBER 11, 2023

ANAHEIM, Calif. — Thousands of workers in the medical device industry gathered here this week for the MedTech Conference, creating an eerie dissonance with Disneyland tourists clad in Mickey Mouse ears and fanny packs. Device makers and analysts at the conference, hosted by device lobby AdvaMed, came together to discuss medical technology’s innovation problem, the industry’s deepening relationship with the Food and Drug Administration, and the growing opportunities in digita

FDA 123

FDA 123

Advertisement

Are you still using workarounds to manage your daily operations? To achieve peak performance, it's time to explore other options for specialty and infusion pharmacy software. Streamline pharmacy operations and improve clinical performance with automated processing, real-time data exchange, and electronic decision support. Download this helpful infographic to: Drive efficiency and patient adherence from referral receipt to delivery and ongoing care – all with our Pharmacy Cloud.

Pharmacy Management Software

Fierce Pharma

OCTOBER 11, 2023

Pfizer has agreed to pay $50 million to resolve a class-action, antitrust case which alleged the company teamed up with others to delay the entry of a generic version of the EpiPen allergy relief m | Pfizer has agreed to pay $50 million to resolve a class-action, antitrust case which alleged the company teamed up with others to delay the entry of a generic version of the EpiPen allergy relief medicine.

121

121

STAT

OCTOBER 11, 2023

Anticipation may be high that Medicare can wring lower prices out of drugmakers, but a handful of states are moving aggressively to slash costs for their residents, a clear sign the battle over affordable medicines in the U.S. is only going to escalate further. These efforts involve Prescription Drug Affordability Boards, which are designed to function like a rate-setting authority.

121

121

Drug Topics

OCTOBER 11, 2023

A new study found that more patients hospitalized with RSV needed standard flow oxygen, HFNC, NIV, and ICU admission than the patients with COVID-19 and influenza.

Hospitals 76

Hospitals 76

STAT

OCTOBER 11, 2023

Chronic kidney disease was the strongest risk factor for sudden cardiac arrest among Hispanic and Latino adults in the first study to evaluate this population in the U.S. for risk factors of this major cause of death. Researchers from Cedars–Sinai Medical Center in Los Angeles identified clinical predictors that influence out-of-hospital sudden cardiac arrest (SCA) — an emergency in which the heart stops beating that affects 350,000 individuals in the United States annually.

Hospitals 118

Hospitals 118

Fierce Pharma

OCTOBER 11, 2023

That didn't take long. | Just two weeks after Biogen completed its buyout of Reata Pharmaceuticals, the combined company is trimming its staff. Reata staffers who worked in roles that are already covered at Biogen are losing their jobs.

112

112

STAT

OCTOBER 11, 2023

Bruce Broussard, CEO of health insurance giant Humana, will step down next year after leading the company for more than a decade. Humana named Jim Rechtin — who is the CEO of Envision Healthcare, the controversial physician staffing firm that is working its way through bankruptcy — as Broussard’s replacement. Rechtin will serve as president and chief operating officer starting Jan. 8 and then take over as CEO in the “latter half of 2024,” the company said in a

Insurance 112

Insurance 112

European Pharmaceutical Review

OCTOBER 11, 2023

Late-breaking data from Roche’s Phase III OCARINA II study have revealed that OCREVUS® (ocrelizumab) subcutaneous injection was comparable to IV infusion in providing near-complete suppression of MRI brain lesion activity over 24 weeks, for relapsing or primary progressive multiple sclerosis (RMS or PPMS) patients. OCREVUS is a humanised monoclonal antibody designed to target CD20-positive B cells, which are thought to be a key contributor to myelin and axonal (nerve cell) damage, noted Roche.

111

111

Fierce Healthcare

OCTOBER 11, 2023

Humana CEO Bruce Broussard will step down from the role in the latter part of 2024, and the insurer has already found a successor. | Humana CEO Bruce Broussard will step down from the role in the latter part of 2024, and the insurer has already found a successor.

Insurance 110

Insurance 110

Fierce Pharma

OCTOBER 11, 2023

Mallinckrodt has essentially walked back its promise to pay $1.7 billion in an opioid settlement thanks to the company's second bankruptcy in just two years. | Mallinckrodt has essentially walked back its promise to pay $1.7 billion in an opioid settlement thanks to the company's second bankruptcy in just two years.

110

110

Fierce Healthcare

OCTOBER 11, 2023

Des Moines, Iowa-based UnityPoint Health and Albuquerque, New Mexico-based Presbyterian Healthcare Services are no longer working toward a merger, the systems announced Wednesday. | The cross-market deal would have yielded a 48-hospital nonprofit with more than 4 million patients. The Iowa- and New Mexico-based organizations did not disclose a specific reason for their decision, though outside reports say UnityPoint's CEO has also stepped down.

Hospitals 110

Hospitals 110

Fierce Pharma

OCTOBER 11, 2023

In the race to develop nonsteroidal topical treatments for autoimmune skin conditions, Dermavant is charging toward the finish line—again. | Dermavant has presented evidence that Vtama provides immediate and long-term relief from the severe itch condition pruritus, the most prevalent symptom of atopic dermatitis. The trial results bolster Dermavant's effort to win a label expansion for the drug.

Labelling 110

Labelling FDA 110

STAT

OCTOBER 11, 2023

A company that Pfizer blamed for problems with a clinical trial testing a Lyme vaccine claims that regulators gave its procedures a clean bill of health during a recent inspection. Care Access served as a contract research organization and had enrolled about 3,000 patients in the late-stage trial. But the patients were dropped last February after Pfizer and its partner, Valneva, claimed that violations of Good Clinical Practice — the international ethical and quality standards used by all

Vaccines 109

Vaccines 109

Drug Store News

OCTOBER 11, 2023

As part of the partnership, Sir John will support the brand’s portfolio of strip lashes and adhesives and also have a dedicated webpage with exclusive content.

116

116

STAT

OCTOBER 11, 2023

LONDON — This week, European regulators are considering an appeal from Amylyx Pharmaceuticals after initially recommending against approving the company’s ALS treatment — the latest potential turning point for a drug that has seen its share of ups and downs with regulatory bodies. In June, a European Medicines Agency committee issued a negative review of Amylyx’s drug, called Albrioza, and cast doubt on whether it had demonstrated effectiveness in its pivotal study.

108

108

The Checkup by Singlecare

OCTOBER 11, 2023

Getting a cold during pregnancy can be a hassle: Not only do you have even more reasons to feel tired, achy, and uncomfortable, but you also have to find pregnancy-safe medications to treat your symptoms. Many traditional cold medicines are safe to use during pregnancy, but some aren’t—and still others are only safe to use during certain trimesters.

Mayo Clinic 106

Mayo Clinic Immunization FDA Compounding 106

STAT

OCTOBER 11, 2023

Hello, everyone, and how are you this fine, sunny morning? The middle of the week has arrived, as you may know, so why not celebrate with a delicious cup of stimulation? After all, you made it this far, which is a likely sign of surviving another few days. And of course, no prescription is required, which is a good thing. Our choice today is hazelnut creme.

FDA 107

FDA 107

Drug Store News

OCTOBER 11, 2023

No longer for young audiences, TikTok is one of the most important social media platforms that marketers need to leverage. Part two of this series gives you four more strategies to consider.

105

105

Fierce Pharma

OCTOBER 11, 2023

GSK resolved a group of claims in California over heartburn medication Zantac. But the company is hardly out of the woods in the wide-ranging litigation. | GSK resolved a group of claims in California over heartburn medication Zantac. But the company is hardly out of the woods in the wide-ranging litigation.

105

105

Drug Store News

OCTOBER 11, 2023

Featuring 5 g of protein per serving, the Quaker Chewy Granola cereal does not have color from artificial sources and does not contain artificial preservatives or flavors.

105

105

STAT

OCTOBER 11, 2023

LONDON — The Wellcome Trust — the world’s second largest private funder of biomedical research — announced on Wednesday that Norwegian scientist and public health official John-Arne Røttingen has been appointed its new CEO.   Røttingen, currently the ambassador for global health in Norway, will start in January at the London-based charity.

100

100